Steele v. Organon, Inc.

716 P.2d 920, 43 Wash. App. 230
CourtCourt of Appeals of Washington
DecidedMarch 25, 1986
Docket6719-0-III
StatusPublished
Cited by33 cases

This text of 716 P.2d 920 (Steele v. Organon, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals of Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Steele v. Organon, Inc., 716 P.2d 920, 43 Wash. App. 230 (Wash. Ct. App. 1986).

Opinions

Thompson, J.

Doris Steele appeals the Superior Court's summary dismissal of her medical malpractice action against Skaggs Drug Centers and Elizabeth Welty, M.D. The court determined the action was filed after the applicable statute of limitation had run. We affirm.

[231]*231In late July 1973, Mrs. Steele was hospitalized under the care of Dr. Welty for a severe migraine headache. Upon discharge, Dr. Welty prescribed a drug called Wigraine, and Mrs. Steele had the prescription filled at a Skaggs drugstore. Directions advised her to take: "Two tablets at onset of headache. [R]epeat every half to one hour for three doses."

Wigraine is an ergot, a vascular constrictor, and though dosage should not exceed 10 to 12 tablets per week, Mrs. Steele began taking 8 tablets a day for her headaches. After approximately 3 weeks, she experienced loss of sensation in her arms and legs and was again admitted to the hospital, this time with ergot poisoning. Drs. Richard Kleaveland and Michael Judd, heart specialists, treated her until her symptoms subsided, at which time she was released. Some months later she returned to Drs. Kleaveland and Judd complaining of tingling in her hands and feet, which they diagnosed as Raynaud's Syndrome.

In September 1974, Mrs. Steele sought advice from an attorney as to whether she had a cause of action for damages resulting from the overdose. The attorney exchanged the following correspondence with Drs. Kleaveland and Judd:

Dear Dr. Judd:
. . . [P] lease advise:
1. What [e] fleets abuse of Wigraine can have on the vascular system.
2. Whether you have found indications of any damage to Mrs. Steele's vascular system which could be attributed, either as an original cause or as an aggravating factor, to Wigraine.
3. If you have found indications of damage to or disease of the vascular system in Mrs. Steele, to what do you attribute them if not to Wigraine.
Dr. Kleaveland replied:
January 8 1975
... In answer to your question one, Wigraine which [232]*232contains ergot causes diffuse spasm in the vascular system and if this is prolonged can induce ischemia or lack of circulation to the tissues with resultant damage to the tissues. In answer to question number two, Mrs. Steele was fortunate in that she recovered from this medication by withholding the medication permitting the level of ergotamine to fall and thus reduction in the spasm with restoration of normal circulation. In answer to question number three, patients may have a variety of different normally occurring vasospastic disorders causing tingling and color changes in the lower extremities, which may not be related to any medication. . . . The intervening period of time between the treatment in the hospital and the present symptoms would somewhat militate against being related to the medication.

A more detailed response followed on February 5, 1975. It stated that Mrs. Steele

did have reduction in circulation in the lower extremities [as a result of the overdose] but the pulses came back rather readily while in the hospital without any evidence of any ischemic changes. She was subsequently seen in our office following the discharge . . . without significant symptoms.

Dr. Kleaveland was of the opinion: " [I]t is highly improbable that there would be any relationship between this episode and her present symptoms [i.e., Raynaud's Syndrome]."

Based on the foregoing, damages from the overdose appeared limited to the August 1973 hospitalization. Since insurance had covered most of the expenses connected with that hospitalization, Mrs. Steele and her attorney decided the cost of a lawsuit could exceed the amount of recovery.

Then, in early December 1981, Mrs. Steele suffered a heart attack. She reentered the hospital in January 1982 for bypass surgery, and, while hospitalized, she suffered a stroke. Dr. Bozarth, a neurologist, told Mrs. Steele the stroke was unrelated to the heart surgery, but during her hospitalization she overheard Dr. Bozarth and another physician discussing the 1973 overdose episode in relation to her stroke. Subsequently, a doctor she consulted in [233]*233Hoquiam, Washington, advised her the heart attack and stroke were both related to the Wigraine overdose.

In December 1982, this action was filed against Dr. Welty, Skaggs Drug Centers, and Organon Pharmaceutical, the manufacturer of Wigraine. Organon was dismissed pursuant to stipulation of the parties. Dr. Welty and Skaggs moved for summary judgment contending the statute of limitation had run. The court granted the motion, stating Mrs. Steele "was aware of all of the elements of her cause of action ... in the latter part of April, 1975", more than 7 years prior to commencement of this action.

At that time, RCW 4.16.350 provided:

Any civil action for damages . . . against a member of the healing arts including, but not limited to, a physician . . . based upon alleged professional negligence shall be commenced within (1) three years from the date of the alleged wrongful act, or (2) one year from the time that plaintiff discovers the injury or condition was caused by the wrongful act, whichever period of time expires last.

Laws of 1971, ch. 80, § 1 (amended by Laws of 1975, 2d Ex. Sess., ch. 56, § 1). Initially, we note the foregoing statute of limitation does not begin to run until the plaintiff discovers or reasonably should have discovered all of the essential elements of his or her cause of action, i.e., duty, breach, causation, damages. Ohler v. Tacoma Gen. Hosp., 92 Wn.2d 507, 511, 598 P.2d 1358 (1979). Mrs. Steele contends an issue of fact exists as to when she discovered she was damaged.

Here, it is undisputed that in April 1975, Mrs. Steele knew that neither her doctor nor the pharmacy, both of whom owed her a duty of care, had warned of the need to limit her intake of Wigraine, and that as a result she overdosed necessitating hospitalization. But Mrs. Steele argues the damage element of a cause of action against the defendants was missing until 1981, when she suffered the heart attack. We disagree.

A plaintiff must suffer actual and appreciable harm, as distinguished from nominal damages, before the statute [234]*234of limitation commences. Gazija v. Nicholas Jems Co., 86 Wn.2d 215, 219, 543 P.2d 338 (1975).

"Where an injury, although slight, is sustained in consequence of the wrongful act of another, and the law affords a remedy therefor, the statute of limitations attaches at once. It is not material that all the damages resulting from the act shall have been sustained at that time, and the running of the statute is not postponed by the fact that the actual or substantial damages do not occur until a later date."

Lindquist v. Mullen, 45 Wn.2d 675, 677, 277 P.2d 724 (1954) (quoting 34 Am. Jur.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sarah Nunley v. Chelan-Douglas Health District
Court of Appeals of Washington, 2024
Kevin Scott Christian v. Thomas F. Stark
Court of Appeals of Washington, 2019
EPIC, a non-profit corporation v. CliftonLarsonAllen LLP
199 Wash. App. 257 (Court of Appeals of Washington, 2017)
Rabo Agrifinance, Inc. v. Bliss
227 F. Supp. 3d 1249 (D. Utah, 2017)
Goodwin v. Bayer Corp.
624 S.E.2d 562 (West Virginia Supreme Court, 2005)
Niven v. E.J. Bartells Co.
983 P.2d 1193 (Court of Appeals of Washington, 1999)
Green v. A.P.C.
960 P.2d 912 (Washington Supreme Court, 1998)
Green v. APC (Am. Pharmaceutical Co.)
960 P.2d 912 (Washington Supreme Court, 1998)
Howlett v. Weslo, Inc.
951 P.2d 831 (Court of Appeals of Washington, 1998)
Green v. American Pharmaceutical Co.
935 P.2d 652 (Court of Appeals of Washington, 1997)
Louisiana-Pacific Corp. v. Asarco Inc.
13 F.3d 1378 (Ninth Circuit, 1994)
First Maryland Leasecorp v. Rothstein
864 P.2d 17 (Court of Appeals of Washington, 1993)
Hinman v. Yakima School District No. 7
850 P.2d 536 (Court of Appeals of Washington, 1993)
Zaleck v. Everett Clinic
802 P.2d 826 (Court of Appeals of Washington, 1991)
Johnson v. Reehoorn
784 P.2d 1301 (Court of Appeals of Washington, 1990)
Adams v. Allen
783 P.2d 635 (Court of Appeals of Washington, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
716 P.2d 920, 43 Wash. App. 230, Counsel Stack Legal Research, https://law.counselstack.com/opinion/steele-v-organon-inc-washctapp-1986.